Dynamic Technology Lab Private LTD Iveric Bio, Inc. Transaction History

Dynamic Technology Lab Private LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $31,592 - $47,714	1,204 Added 8.58%	15,242 $599,000
Q1 2023 May 12, 2023	BUY	$18.67 - $24.56 $262,089 - $344,773	14,038 New	14,038 $341,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $456,482 - $902,767	-48,562 Reduced 71.26%	19,585 $351,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $456,482 - $902,767	-48,562 Reduced 71.26%	19,585 $351,000
Q2 2022 Aug 12, 2022	BUY	$9.12 - $18.9 $621,500 - $1.29 Million	68,147 New	68,147 $656,000

Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $72,955 - $180,582	-10,319 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.69 - $7.17 $58,715 - $73,987	10,319 New	10,319 $65,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $89,118 - $120,871	-17,543 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.65 - $7.66 $99,117 - $134,379	17,543 New	17,543 $121,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.